DaVita Inc. (0I7E.L)
USD 140.66
(-2.32%)
USD 140.66
(-2.32%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 12.14 Billion USD | 4.57% |
| 2022 | 11.6 Billion USD | -0.08% |
| 2021 | 11.61 Billion USD | 0.59% |
| 2020 | 11.55 Billion USD | 1.42% |
| 2019 | 11.38 Billion USD | -0.14% |
| 2018 | 11.4 Billion USD | 4.86% |
| 2017 | 10.87 Billion USD | -26.24% |
| 2016 | 14.74 Billion USD | 6.99% |
| 2015 | 13.78 Billion USD | 7.71% |
| 2014 | 12.79 Billion USD | 8.76% |
| 2013 | 11.76 Billion USD | 43.7% |
| 2012 | 8.18 Billion USD | 20.53% |
| 2011 | 6.79 Billion USD | 5.34% |
| 2010 | 6.44 Billion USD | 5.54% |
| 2009 | 6.1 Billion USD | 7.93% |
| 2008 | 5.66 Billion USD | 7.52% |
| 2007 | 5.26 Billion USD | 7.86% |
| 2006 | 4.88 Billion USD | 64.12% |
| 2005 | 2.97 Billion USD | 29.38% |
| 2004 | 2.29 Billion USD | 12.32% |
| 2003 | 2.04 Billion USD | 10.34% |
| 2002 | 1.85 Billion USD | 12.35% |
| 2001 | 1.65 Billion USD | 11.06% |
| 2000 | 1.48 Billion USD | 2.83% |
| 1999 | 1.44 Billion USD | 19.96% |
| 1998 | 1.2 Billion USD | 174.97% |
| 1997 | 438.2 Million USD | 60.57% |
| 1996 | 272.9 Million USD | 204.24% |
| 1995 | 89.7 Million USD | -9.39% |
| 1994 | 99 Million USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 3.07 Billion USD | -2.39% |
| 2024 Q3 | 3.26 Billion USD | 2.41% |
| 2024 Q2 | 3.18 Billion USD | 3.78% |
| 2023 Q1 | 2.87 Billion USD | -1.51% |
| 2023 Q3 | 3.12 Billion USD | 4.03% |
| 2023 Q4 | 3.14 Billion USD | 0.78% |
| 2023 FY | 12.14 Billion USD | 4.57% |
| 2023 Q2 | 3 Billion USD | 4.44% |
| 2022 Q2 | 2.92 Billion USD | 3.88% |
| 2022 Q1 | 2.81 Billion USD | -4.29% |
| 2022 FY | 11.6 Billion USD | -0.08% |
| 2022 Q3 | 2.94 Billion USD | 0.75% |
| 2022 Q4 | 2.91 Billion USD | -1.08% |
| 2021 Q2 | 2.91 Billion USD | 3.42% |
| 2021 Q1 | 2.82 Billion USD | -2.94% |
| 2021 Q3 | 2.93 Billion USD | 0.75% |
| 2021 Q4 | 2.94 Billion USD | 0.19% |
| 2021 FY | 11.61 Billion USD | 0.59% |
| 2020 Q3 | 2.92 Billion USD | 1.53% |
| 2020 FY | 11.55 Billion USD | 1.42% |
| 2020 Q2 | 2.87 Billion USD | 1.36% |
| 2020 Q1 | 2.84 Billion USD | -1.98% |
| 2020 Q4 | 2.9 Billion USD | -0.64% |
| 2019 FY | 11.38 Billion USD | -0.14% |
| 2019 Q2 | 2.84 Billion USD | 3.63% |
| 2019 Q4 | 2.89 Billion USD | -0.19% |
| 2019 Q1 | 2.74 Billion USD | -2.77% |
| 2019 Q3 | 2.9 Billion USD | 2.16% |
| 2018 Q1 | 2.84 Billion USD | 2.46% |
| 2018 Q4 | 2.82 Billion USD | -0.92% |
| 2018 Q2 | 2.88 Billion USD | 1.32% |
| 2018 Q3 | 2.84 Billion USD | -1.37% |
| 2018 FY | 11.4 Billion USD | 4.86% |
| 2017 Q4 | 2.78 Billion USD | -29.11% |
| 2017 Q3 | 3.92 Billion USD | 1.17% |
| 2017 FY | 10.87 Billion USD | -26.24% |
| 2017 Q1 | 3.69 Billion USD | -0.5% |
| 2017 Q2 | 3.87 Billion USD | 4.87% |
| 2016 Q1 | 3.58 Billion USD | 1.35% |
| 2016 Q4 | 3.71 Billion USD | -0.4% |
| 2016 Q3 | 3.73 Billion USD | 0.35% |
| 2016 FY | 14.74 Billion USD | 6.99% |
| 2016 Q2 | 3.71 Billion USD | 3.81% |
| 2015 Q3 | 3.52 Billion USD | 2.65% |
| 2015 Q2 | 3.43 Billion USD | 4.46% |
| 2015 Q1 | 3.28 Billion USD | -1.2% |
| 2015 FY | 13.78 Billion USD | 7.71% |
| 2015 Q4 | 3.53 Billion USD | 0.22% |
| 2014 Q3 | 3.25 Billion USD | 2.5% |
| 2014 Q1 | 3.04 Billion USD | -0.67% |
| 2014 Q4 | 3.32 Billion USD | 2.34% |
| 2014 FY | 12.79 Billion USD | 8.76% |
| 2014 Q2 | 3.17 Billion USD | 4.26% |
| 2013 FY | 11.76 Billion USD | 43.7% |
| 2013 Q4 | 3.06 Billion USD | 2.12% |
| 2013 Q3 | 2.99 Billion USD | 4.45% |
| 2013 Q2 | 2.87 Billion USD | 1.49% |
| 2013 Q1 | 2.82 Billion USD | 14.19% |
| 2012 Q3 | 1.96 Billion USD | 1.72% |
| 2012 Q1 | 1.86 Billion USD | 0.23% |
| 2012 Q2 | 1.92 Billion USD | 3.38% |
| 2012 Q4 | 2.47 Billion USD | 26.23% |
| 2012 FY | 8.18 Billion USD | 20.53% |
| 2011 Q2 | 1.71 Billion USD | 6.57% |
| 2011 Q4 | 1.86 Billion USD | 3.01% |
| 2011 FY | 6.79 Billion USD | 5.34% |
| 2011 Q1 | 1.6 Billion USD | -2.63% |
| 2011 Q3 | 1.8 Billion USD | 5.63% |
| 2010 FY | 6.44 Billion USD | 5.54% |
| 2010 Q4 | 1.64 Billion USD | -0.14% |
| 2010 Q3 | 1.65 Billion USD | 4.08% |
| 2010 Q2 | 1.58 Billion USD | 1.76% |
| 2010 Q1 | 1.55 Billion USD | -0.56% |
| 2009 FY | 6.1 Billion USD | 7.93% |
| 2009 Q4 | 1.56 Billion USD | -0.36% |
| 2009 Q3 | 1.57 Billion USD | 3.61% |
| 2009 Q2 | 1.51 Billion USD | 4.93% |
| 2009 Q1 | 1.44 Billion USD | -0.92% |
| 2008 Q2 | 1.4 Billion USD | 4.65% |
| 2008 Q1 | 1.34 Billion USD | -0.75% |
| 2008 FY | 5.66 Billion USD | 7.52% |
| 2008 Q4 | 1.46 Billion USD | 0.96% |
| 2008 Q3 | 1.44 Billion USD | 2.83% |
| 2007 Q1 | 1.27 Billion USD | 0.44% |
| 2007 Q4 | 1.35 Billion USD | 2.77% |
| 2007 Q3 | 1.31 Billion USD | 0.43% |
| 2007 Q2 | 1.31 Billion USD | 2.7% |
| 2007 FY | 5.26 Billion USD | 7.86% |
| 2006 FY | 4.88 Billion USD | 64.12% |
| 2006 Q4 | 1.27 Billion USD | 2.88% |
| 2006 Q3 | 1.23 Billion USD | 2.42% |
| 2006 Q2 | 1.2 Billion USD | 3.84% |
| 2006 Q1 | 1.16 Billion USD | 12.05% |
| 2005 Q2 | 649.04 Million USD | 6.41% |
| 2005 FY | 2.97 Billion USD | 29.38% |
| 2005 Q4 | 1.03 Billion USD | 53.38% |
| 2005 Q3 | 676.82 Million USD | 4.28% |
| 2005 Q1 | 609.95 Million USD | -0.98% |
| 2004 FY | 2.29 Billion USD | 12.32% |
| 2004 Q4 | 616 Million USD | 3.44% |
| 2004 Q3 | 595.53 Million USD | 7.96% |
| 2004 Q2 | 551.63 Million USD | 3.03% |
| 2004 Q1 | 535.43 Million USD | -8.23% |
| 2003 Q3 | 513.28 Million USD | 4.78% |
| 2003 Q2 | 489.88 Million USD | 6.54% |
| 2003 FY | 2.04 Billion USD | 10.34% |
| 2003 Q1 | 459.8 Million USD | -8.6% |
| 2003 Q4 | 583.44 Million USD | 13.67% |
| 2002 Q2 | 442.67 Million USD | 3.51% |
| 2002 Q1 | 427.66 Million USD | -0.46% |
| 2002 Q3 | 481.19 Million USD | 8.7% |
| 2002 FY | 1.85 Billion USD | 12.35% |
| 2002 Q4 | 503.09 Million USD | 4.55% |
| 2001 Q3 | 434.23 Million USD | 8.39% |
| 2001 FY | 1.65 Billion USD | 11.06% |
| 2001 Q1 | 386.21 Million USD | 3.61% |
| 2001 Q4 | 429.65 Million USD | -1.06% |
| 2001 Q2 | 400.64 Million USD | 3.73% |
| 2000 Q4 | 372.74 Million USD | 2.82% |
| 2000 Q1 | 372.11 Million USD | -0.22% |
| 2000 Q3 | 362.53 Million USD | -4.32% |
| 2000 FY | 1.48 Billion USD | 2.83% |
| 2000 Q2 | 378.9 Million USD | 1.83% |
| 1999 Q2 | 353 Million USD | 0.23% |
| 1999 FY | 1.44 Billion USD | 19.96% |
| 1999 Q1 | 352.2 Million USD | 3.83% |
| 1999 Q4 | 372.95 Million USD | 1.62% |
| 1999 Q3 | 367 Million USD | 3.97% |
| 1998 Q1 | 258.7 Million USD | 97.93% |
| 1998 FY | 1.2 Billion USD | 174.97% |
| 1998 Q4 | 339.2 Million USD | 6.47% |
| 1998 Q3 | 318.6 Million USD | 10.51% |
| 1998 Q2 | 288.3 Million USD | 11.44% |
| 1997 FY | 438.2 Million USD | 60.57% |
| 1997 Q3 | 113.7 Million USD | 8.49% |
| 1997 Q2 | 104.8 Million USD | 17.75% |
| 1997 Q1 | 89 Million USD | 5.08% |
| 1997 Q4 | 130.7 Million USD | 14.95% |
| 1996 Q1 | 50.2 Million USD | 27.41% |
| 1996 Q2 | 64.6 Million USD | 28.69% |
| 1996 Q3 | 73.3 Million USD | 13.47% |
| 1996 Q4 | 84.7 Million USD | 15.55% |
| 1996 FY | 272.9 Million USD | 204.24% |
| 1995 Q4 | 39.4 Million USD | 10.36% |
| 1995 Q3 | 35.7 Million USD | 43.95% |
| 1995 FY | 89.7 Million USD | -9.39% |
| 1995 Q2 | 24.8 Million USD | 0.0% |
| 1995 Q1 | 24.8 Million USD | 0.4% |
| 1994 Q4 | 24.7 Million USD | 0.0% |
| 1994 FY | 99 Million USD | 0.0% |
| 1994 Q3 | 24.7 Million USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Phreesia, Inc. | 356.29 Million USD | -3307.292% |
| Accuray Incorporated | 446.55 Million USD | -2618.647% |
| Align Technology, Inc. | 3.86 Billion USD | -214.328% |
| Elevance Health Inc. | 171.34 Billion USD | 92.915% |
| AxoGen, Inc. | 159.01 Million USD | -7534.736% |
| Boston Scientific Corporation | 14.24 Billion USD | 14.746% |
| CVS Health Corporation | 357.77 Billion USD | 96.607% |
| Cardinal Health, Inc. | 226.82 Billion USD | 94.648% |
| Centene Corporation | 141.26 Billion USD | 91.406% |
| HCA Healthcare, Inc. | 64.96 Billion USD | 81.314% |
| Hologic, Inc. | 4.03 Billion USD | -201.222% |
| Humana Inc. | 106.37 Billion USD | 88.587% |
| IDEXX Laboratories, Inc. | 3.66 Billion USD | -231.612% |
| Laboratory Corporation of America Holdings | 12.16 Billion USD | 0.176% |
| Masimo Corporation | 2.04 Billion USD | -492.752% |
| McKesson Corporation | 308.95 Billion USD | 96.071% |
| Patterson Companies, Inc. | 6.56 Billion USD | -84.83% |
| Quest Diagnostics Incorporated | 9.25 Billion USD | -31.216% |
| ResMed Inc. | 4.68 Billion USD | -159.112% |
| Henry Schein, Inc. | 12.33 Billion USD | 1.612% |
| Teladoc Health, Inc. | 2.6 Billion USD | -366.495% |
| Universal Health Services, Inc. | 14.28 Billion USD | 14.997% |
| Veeva Systems Inc. | 2.36 Billion USD | -413.614% |
| Baxter International Inc. | 14.81 Billion USD | 18.044% |
| Becton, Dickinson and Company | 19.37 Billion USD | 37.331% |
| Intuitive Surgical, Inc. | 7.12 Billion USD | -70.41% |
| Danaher Corporation | 23.89 Billion USD | 49.183% |
| Stryker Corporation | 20.49 Billion USD | 40.774% |
| Medtronic plc | 32.36 Billion USD | 62.489% |